Patient Study 2026
Hair Health Barometer
2026
A primary data survey of 563 patients on emotional burden, decision pathways and satisfaction relating to hair transplantation. Conducted in February 2026.
Six central results of the survey
The figures below represent the most important findings of the study. They shed light on how long people live with hair loss before seeking treatment, how patients gather information, and how they assess the treatment in retrospect.
Emotional burden
Seven in ten respondents say they experience hair loss as a significant or very significant emotional burden.
Suffering for over five years
41.9% of patients report having lived with hair loss for more than five years before considering a hair transplant.
Willingness to recommend
96.1% of respondents would recommend the treatment or at least consider doing so. Only 3.9% explicitly rule out a recommendation.
Research via search engine
58.6% of patients cite Google search as one of their information channels. Personal recommendations follow at 42.6% (multiple responses permitted).
Gender distribution
96.6% of respondents are male, 3.2% female. The most common age group is 35 to 44 years.
Critical perception
22% of respondents also associate hair transplant clinics with the term “production line”. At the same time, 67.9% rate their treating clinic as professional.
Who was surveyed?
The survey was addressed exclusively to people who have already completed a hair transplant. The composition of the sample provides an insight into the profile of those currently choosing this treatment.
The occupational spread is broad: self-employed people and entrepreneurs (16.9%), construction and trades (15.5%), and IT and technology (14.6%) are the most frequently represented. The lifestyle questions reveal a strong affinity for sport and physical activity. This corresponds with a further finding: 92.6% of respondents say their outward appearance is important or very important to them.
Demographic cross-section
Overall, the sample describes a professionally active, middle-aged group with stable social integration. The income distribution ranges from under £2,000 net (6.4%) to over £5,000 net (17.9%), with a concentration between £2,000 and £3,500 (31.3%).
Between the first symptoms and treatment lie years.
A central finding of the study concerns the time between first noticing hair loss and the moment when treatment is considered. For most respondents this phase lasts several years and is frequently accompanied by a noticeable emotional burden.
70% of respondents describe their emotional burden as significant or very significant.
50.8% say hair loss had a significant impact on them and they wanted to do something about it. 19.2% describe the burden as very significant. A further 22.2% rate it as moderate. Only 2.8% say they considered treatment without any emotional motivation.
The study captures four points in time along the patient journey. They show that several years can pass between first noticing hair loss and undergoing treatment, and that price assessments frequently shift after booking.
Chapter 2 summary
94.5% of respondents had been experiencing hair loss for at least one year before considering treatment, and 41.9% for more than five years. 43% take more than a year to deliberate after their initial consideration before booking the procedure.
How do people inform themselves before making a decision?
The study recorded which information channels patients used before their treatment. Multiple responses were permitted. The analysis shows that online research and personal recommendations are the two most frequently cited sources.
Taken together, the two most frequently cited channels — Google search and personal recommendation — account for over 100% in multiple responses. A large proportion of respondents therefore combines independent online research with conversations in their social circles. Traditional advertising formats (print, TV, out-of-home) are mentioned only sporadically in the survey.
Striking is the high importance placed on user-generated content: patient reviews in forums (28.2%) and videos on platforms such as Instagram, TikTok or YouTube (36.6%) are cited more often than conventional doctor recommendations. This indicates that patients actively compare and draw on independent sources before reaching their decision.
Chapter 3 summary
More than 70% of respondents arrive at their clinic via organic search or personal recommendation. The results suggest that patients base their decisions on research they can verify for themselves.
What terms do patients associate with their clinic?
Participants were able to select both positive and critical attributes in a multiple-choice format. The questionnaire design deliberately left room for negative responses. The following comparison shows the most frequently cited positive associations and the most relevant critical perceptions.
Perception in contrast
Positive attributes dominate: professional (67.9%), skilled (61.3%), modern (54.5%), personable and customer-focused (35.7%) and innovative (29.5%).
At the same time, a critical perception pattern exists: 22% of respondents also associate their clinic with the term “production line”, 17.1% cite quality uncertainty, and only 9.6% describe their care as explicitly individual. Elithair takes these results as an indicator of the need to make individualised care processes such as the 5-Doctor Concept and the Pre-Test System more visible to patients.
Chapter 4 summary
The perception among the surveyed patients is overwhelmingly positive (professionalism, expertise, modernity). The critical share of 22% for “production line” is documented as an indication of areas where the personalisation of care can be further strengthened.
Assessment of the treatment outcome
Participants were asked after completing treatment how satisfied they were with the outcome and whether they would recommend the treatment. The two metrics are closely interrelated.
Satisfied with the outcome
93.7% rate the treatment outcome from neutral to very satisfied. Only 6.3% express explicit dissatisfaction.
Would consider making a recommendation
The range extends from “depends on the situation” to “absolutely”. Only 3.9% explicitly rule out a recommendation.
Both metrics reinforce each other: 93.7% positive to neutral outcome ratings correspond with 96.1% general willingness to recommend. The link between outcome acceptance and propensity to recommend is clearly demonstrable and explains the high importance of personal recommendations as an information source documented in Chapter 3.
The post-treatment price assessment is also clearly positive: 86.3% of respondents consider the price reasonable or good value in retrospect (79% reasonable, 7.3% good value). Only 13.7% rate it as expensive.
Open responses from participants
Everything was perfect, from being collected at the airport to the operation itself.
Patient, positive feedback on the service experience
Shop purchases should appear in the app — as individual appointments for the applications in the calendar.
Patient, suggestion regarding product and app integration
More attention to individual concerns would be appreciated.
Patient, critical feedback
Chapter 5 summary
93.7% of respondents rate the outcome from neutral to very satisfied, and 96.1% would recommend the treatment or at least consider doing so in the right circumstances. The proportion explicitly dissatisfied stands at 6.3%, and those categorically unwilling to recommend at 3.9%. Outcome acceptance and willingness to recommend correlate strongly.
Hair loss is a global healthcare issue.
The data collected here can be placed in a broader international context. National dermatological studies and market analyses show that hair loss in men is comparable in scale across most Western and Arab countries. The following figures are drawn from published third-party sources.
Germany & DACH
563Respondents in this study. Core market with the deepest data foundation.
United Kingdom
~47%Of men under 50 are affected by measurable hair loss. Source: British Journal of Dermatology.
France
45%Of men over 35 show significant alopecia. High awareness, limited local provision.
Saudi Arabia & UAE
Top 5Hair transplantation is one of the fastest-growing aesthetic procedures in the GCC region.
Netherlands & BeNeLux
+28%Increase in HT demand since 2022. Growing medical tourism towards Istanbul.
Global market by 2030
$21bnProjected global market volume for hair transplantation. Source: Grand View Research, 2024.
Commentary on the findings
The metrics presented here are placed in context by a brief expert statement from the medical director. It addresses the findings that are most significant from a clinical perspective.
“The long period of suffering before first treatment is the most striking finding.”
41.9% of respondents had lived with hair loss for more than five years before considering treatment. At the same time, 70% describe the emotional burden during this phase as significant to very significant. From a clinical perspective, both findings should be considered together. They indicate that patient education on the causes, progression and treatment options for androgenetic alopecia should accompany a longer period than has typically been the case.
Dr. Balwi · Medical Director, Elithair
Data available for editorial use
All figures from this study may be used in editorial and academic contexts with the attribution “Elithair Hair Health Barometer 2026, n=563”. For press enquiries, raw data or additional analyses, please contact presse@elithair.de.
Cite the Hair Health Barometer
All content from this study may be used with attribution for editorial, academic and informational purposes. The following templates make correct citation straightforward.
Complete citations in three formats
Ready to use in academic papers, articles and blog posts. Would you like raw data, high-resolution graphics or an interview with Dr. Balwi? Write to us at press@elithair.de.
How the study was conducted
The following information on sample, period, questionnaire and limitations enables a well-founded assessment of the findings.
Sample
Surveyperiod
Questionnaire
Inclusioncriterion
Survey topic areas: demographics, lifestyle, decision pathway and time to treatment, information sources, brand perception, experience with the Dr. Balwi shop, satisfaction with the outcome and willingness to recommend. Multiple responses were permitted in the interests and information sources sections; as a result, some totals in those areas exceed 100%.
Limitations: This is a patient survey conducted within a clinic network, not a representative population survey. The sample is therefore suitable for mapping the journey, motivation and satisfaction of the actually treated target group rather than making statements about the general population affected by hair loss. No sample weighting was applied.
Data protection: All responses were processed anonymously. No patient is identifiable in the published findings. Quotes were used with the consent of the respective patients.
Frequently asked questions about the study
May we use individual figures in our own articles?
Yes. Individual percentages, quotes and charts may be used editorially with the attribution “Elithair Hair Health Barometer 2026, n=563”. For more extensive use, such as full graphic re-presentations, we would appreciate a brief note to press@elithair.de.
Is the study available as a PDF or press kit?
A press kit including a PDF, high-resolution graphics and raw data tables can be requested informally at press@elithair.de. For editorial purposes the material is typically provided within 48 hours.
Is an interview with Dr. Balwi possible?
Yes. Requests for press interviews, podcasts or expert contributions should be directed to press@elithair.de. Dr. Balwi is also available on request for English-language formats.
Is the study planned to be repeated regularly?
Yes. The Hair Health Barometer is designed as an annual primary data survey. The development of key metrics such as time to treatment, emotional burden and perception patterns will be tracked across multiple survey years.